ID   FZD5_HUMAN              Reviewed;         585 AA.
AC   Q13467; A8K2X1; B2RCZ1; Q53R22;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   07-APR-2021, entry version 198.
DE   RecName: Full=Frizzled-5;
DE            Short=Fz-5;
DE            Short=hFz5;
DE   AltName: Full=FzE5;
DE   Flags: Precursor;
GN   Name=FZD5; Synonyms=C2orf31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=8626800; DOI=10.1074/jbc.271.8.4468;
RA   Wang Y., Macke J.P., Abella B.S., Andreasson K., Worley P., Gilbert D.J.,
RA   Copeland N.G., Jenkins N.A., Nathans J.;
RT   "A large family of putative transmembrane receptors homologous to the
RT   product of the Drosophila tissue polarity gene frizzled.";
RL   J. Biol. Chem. 271:4468-4476(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11408929; DOI=10.3892/ijo.19.1.105;
RA   Saitoh T., Hirai M., Katoh M.;
RT   "Molecular cloning and characterization of human Frizzled-5 gene on
RT   chromosome 2q33.3-q34 region.";
RL   Int. J. Oncol. 19:105-110(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 273-331.
RC   TISSUE=Esophageal carcinoma;
RX   PubMed=9707618; DOI=10.1073/pnas.95.17.10164;
RA   Tanaka S., Akiyoshi T., Mori M., Wands J.R., Sugimachi K.;
RT   "A novel frizzled gene identified in human esophageal carcinoma mediates
RT   APC/beta-catenin signals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10164-10169(1998).
RN   [6]
RP   FUNCTION, AND COUPLING TO BETA-CATENIN PATHWAY.
RX   PubMed=9054360; DOI=10.1126/science.275.5306.1652;
RA   He X., Saint-Jeannet J.P., Wang Y., Nathans J., Dawid I., Varmus H.;
RT   "A member of the Frizzled protein family mediating axis induction by Wnt-
RT   5A.";
RL   Science 275:1652-1654(1997).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10097073; DOI=10.1073/pnas.96.7.3546;
RA   Hsieh J.C., Rattner A., Smallwood P.M., Nathans J.;
RT   "Biochemical characterization of Wnt-frizzled interactions using a soluble,
RT   biologically active vertebrate Wnt protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:3546-3551(1999).
RN   [8]
RP   INTERACTION WITH WNT2B.
RX   PubMed=12490564; DOI=10.1242/dev.00244;
RA   Kubo F., Takeichi M., Nakagawa S.;
RT   "Wnt2b controls retinal cell differentiation at the ciliary marginal
RT   zone.";
RL   Development 130:587-598(2003).
RN   [9]
RP   INTERACTION WITH WNT7A.
RX   PubMed=18230341; DOI=10.1016/j.bbrc.2008.01.088;
RA   Carmon K.S., Loose D.S.;
RT   "Wnt7a interaction with Fzd5 and detection of signaling activation using a
RT   split eGFP.";
RL   Biochem. Biophys. Res. Commun. 368:285-291(2008).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH WNT7A.
RX   PubMed=20530549; DOI=10.1242/dev.046722;
RA   Sahores M., Gibb A., Salinas P.C.;
RT   "Frizzled-5, a receptor for the synaptic organizer Wnt7a, regulates
RT   activity-mediated synaptogenesis.";
RL   Development 137:2215-2225(2010).
RN   [11]
RP   UBIQUITINATION BY ZNRF3.
RX   PubMed=22575959; DOI=10.1038/nature11019;
RA   Hao H.X., Xie Y., Zhang Y., Charlat O., Oster E., Avello M., Lei H.,
RA   Mickanin C., Liu D., Ruffner H., Mao X., Ma Q., Zamponi R., Bouwmeester T.,
RA   Finan P.M., Kirschner M.W., Porter J.A., Serluca F.C., Cong F.;
RT   "ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.";
RL   Nature 485:195-200(2012).
RN   [12]
RP   UBIQUITINATION BY RNF43.
RX   PubMed=22895187; DOI=10.1038/nature11308;
RA   Koo B.K., Spit M., Jordens I., Low T.Y., Stange D.E., van de Wetering M.,
RA   van Es J.H., Mohammed S., Heck A.J., Maurice M.M., Clevers H.;
RT   "Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis
RT   of Wnt receptors.";
RL   Nature 488:665-669(2012).
RN   [13] {ECO:0007744|PDB:5URY, ECO:0007744|PDB:5URZ}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 28-155 IN COMPLEX WITH
RP   UNSATURATED FATTY ACID, SUBUNIT, GLYCOSYLATION AT ASN-47, AND DISULFIDE
RP   BONDS.
RX   PubMed=28377511; DOI=10.1073/pnas.1618293114;
RA   Nile A.H., Mukund S., Stanger K., Wang W., Hannoush R.N.;
RT   "Unsaturated fatty acyl recognition by Frizzled receptors mediates
RT   dimerization upon Wnt ligand binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:4147-4152(2017).
CC   -!- FUNCTION: Receptor for Wnt proteins (PubMed:9054360, PubMed:10097073,
CC       PubMed:20530549). Can activate WNT2, WNT10B, WNT5A, but not WNT2B or
CC       WNT4 (in vitro); the in vivo situation may be different since not all
CC       of these are known to be coexpressed (By similarity). In neurons,
CC       activation of WNT7A promotes formation of synapses (PubMed:20530549).
CC       Functions in the canonical Wnt/beta-catenin signaling pathway. The
CC       canonical Wnt/beta-catenin signaling pathway leads to the activation of
CC       disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation
CC       of beta-catenin and activation of Wnt target genes (By similarity). A
CC       second signaling pathway involving PKC and calcium fluxes has been seen
CC       for some family members, but it is not yet clear if it represents a
CC       distinct pathway or if it can be integrated in the canonical pathway,
CC       as PKC seems to be required for Wnt-mediated inactivation of GSK-3
CC       kinase. Both pathways seem to involve interactions with G-proteins. May
CC       be involved in transduction and intercellular transmission of polarity
CC       information during tissue morphogenesis and/or in differentiated
CC       tissues (Probable). Plays a role in yolk sac angiogenesis and in
CC       placental vascularization (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EQD0, ECO:0000269|PubMed:10097073,
CC       ECO:0000269|PubMed:20530549, ECO:0000269|PubMed:9054360, ECO:0000305}.
CC   -!- SUBUNIT: Binding of unsaturated fatty acid molecules (via FZ domain)
CC       promotes homodimerization (PubMed:28377511). Interacts with WNT2B
CC       (PubMed:12490564). Interacts with WNT7A (PubMed:18230341,
CC       PubMed:20530549). Interacts with GOPC (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EQD0, ECO:0000269|PubMed:12490564,
CC       ECO:0000269|PubMed:18230341, ECO:0000269|PubMed:20530549,
CC       ECO:0000269|PubMed:28377511}.
CC   -!- INTERACTION:
CC       Q13467; Q6P3W7: SCYL2; NbExp=4; IntAct=EBI-3913027, EBI-1046810;
CC       Q13467; P78383: SLC35B1; NbExp=3; IntAct=EBI-3913027, EBI-12147661;
CC       Q13467; M4NKV9: tcdB; Xeno; NbExp=3; IntAct=EBI-3913027, EBI-20596828;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8CHL0};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:Q8CHL0}. Golgi
CC       apparatus membrane {ECO:0000250|UniProtKB:Q9EQD0}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q9EQD0}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q8CHL0}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q8CHL0}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q8CHL0}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q8CHL0}. Note=Localized at the plasma membrane
CC       and also found at the Golgi. {ECO:0000250|UniProtKB:Q9EQD0}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with GOPC.
CC       {ECO:0000250}.
CC   -!- DOMAIN: Lys-Thr-X-X-X-Trp motif interacts with the PDZ domain of Dvl
CC       (Disheveled) family members and is involved in the activation of the
CC       Wnt/beta-catenin signaling pathway. {ECO:0000250}.
CC   -!- DOMAIN: The FZ domain is involved in binding with Wnt ligands.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by RNF43 and ZNRF3, leading to its degradation by
CC       the proteasome. {ECO:0000269|PubMed:22575959,
CC       ECO:0000269|PubMed:22895187}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor Fz/Smo family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U43318; AAC50385.1; -; mRNA.
DR   EMBL; AB043702; BAB60959.1; -; mRNA.
DR   EMBL; AK290386; BAF83075.1; -; mRNA.
DR   EMBL; AK315338; BAG37738.1; -; mRNA.
DR   EMBL; AC096772; AAY24058.1; -; Genomic_DNA.
DR   CCDS; CCDS33366.1; -.
DR   RefSeq; NP_003459.2; NM_003468.3.
DR   PDB; 5URY; X-ray; 2.10 A; A/B=28-155.
DR   PDB; 5URZ; X-ray; 2.20 A; A/B=28-155.
DR   PDB; 6O39; X-ray; 1.80 A; C=28-150.
DR   PDB; 6WW2; EM; 3.70 A; R=27-428, R=441-546.
DR   PDBsum; 5URY; -.
DR   PDBsum; 5URZ; -.
DR   PDBsum; 6O39; -.
DR   PDBsum; 6WW2; -.
DR   SMR; Q13467; -.
DR   BioGRID; 113609; 18.
DR   CORUM; Q13467; -.
DR   IntAct; Q13467; 17.
DR   MINT; Q13467; -.
DR   STRING; 9606.ENSP00000354607; -.
DR   ChEMBL; CHEMBL3559687; -.
DR   GuidetoPHARMACOLOGY; 233; -.
DR   GlyGen; Q13467; 3 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13467; -.
DR   PhosphoSitePlus; Q13467; -.
DR   BioMuta; FZD5; -.
DR   DMDM; 116242481; -.
DR   EPD; Q13467; -.
DR   jPOST; Q13467; -.
DR   MassIVE; Q13467; -.
DR   MaxQB; Q13467; -.
DR   PaxDb; Q13467; -.
DR   PeptideAtlas; Q13467; -.
DR   PRIDE; Q13467; -.
DR   ProteomicsDB; 59463; -.
DR   TopDownProteomics; Q13467; -.
DR   ABCD; Q13467; 61 sequenced antibodies.
DR   Antibodypedia; 19996; 419 antibodies.
DR   DNASU; 7855; -.
DR   Ensembl; ENST00000295417; ENSP00000354607; ENSG00000163251.
DR   GeneID; 7855; -.
DR   KEGG; hsa:7855; -.
DR   UCSC; uc002vcj.4; human.
DR   CTD; 7855; -.
DR   DisGeNET; 7855; -.
DR   GeneCards; FZD5; -.
DR   HGNC; HGNC:4043; FZD5.
DR   HPA; ENSG00000163251; Tissue enhanced (intestine, liver).
DR   MalaCards; FZD5; -.
DR   MIM; 601723; gene.
DR   neXtProt; NX_Q13467; -.
DR   OpenTargets; ENSG00000163251; -.
DR   Orphanet; 98942; Coloboma of choroid and retina.
DR   Orphanet; 98943; Coloboma of eye lens.
DR   Orphanet; 98946; Coloboma of eyelid.
DR   Orphanet; 98944; Coloboma of iris.
DR   Orphanet; 98945; Coloboma of macula.
DR   Orphanet; 98947; Coloboma of optic disc.
DR   PharmGKB; PA28460; -.
DR   VEuPathDB; HostDB:ENSG00000163251.3; -.
DR   eggNOG; KOG3577; Eukaryota.
DR   GeneTree; ENSGT00940000162639; -.
DR   HOGENOM; CLU_007873_2_0_1; -.
DR   InParanoid; Q13467; -.
DR   OMA; CRADGPQ; -.
DR   OrthoDB; 509772at2759; -.
DR   PhylomeDB; Q13467; -.
DR   TreeFam; TF317907; -.
DR   PathwayCommons; Q13467; -.
DR   Reactome; R-HSA-373080; Class B/2 (Secretin family receptors).
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-HSA-5340588; Signaling by RNF43 mutants.
DR   SignaLink; Q13467; -.
DR   SIGNOR; Q13467; -.
DR   BioGRID-ORCS; 7855; 17 hits in 994 CRISPR screens.
DR   ChiTaRS; FZD5; human.
DR   GeneWiki; FZD5; -.
DR   GenomeRNAi; 7855; -.
DR   Pharos; Q13467; Tbio.
DR   PRO; PR:Q13467; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q13467; protein.
DR   Bgee; ENSG00000163251; Expressed in colonic mucosa and 205 other tissues.
DR   Genevisible; Q13467; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0001540; F:amyloid-beta binding; IPI:ARUK-UCL.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:ARUK-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0042813; F:Wnt-activated receptor activity; IDA:FlyBase.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0008595; P:anterior/posterior axis specification, embryo; IDA:BHF-UCL.
DR   GO; GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:1904886; P:beta-catenin destruction complex disassembly; TAS:Reactome.
DR   GO; GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0071219; P:cellular response to molecule of bacterial origin; IDA:BHF-UCL.
DR   GO; GO:0060718; P:chorionic trophoblast cell differentiation; IEA:Ensembl.
DR   GO; GO:0000578; P:embryonic axis specification; IDA:BHF-UCL.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:ARUK-UCL.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; HMP:ParkinsonsUK-UCL.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine production; IDA:CACAO.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:ARUK-UCL.
DR   GO; GO:0031077; P:post-embryonic camera-type eye development; IEA:Ensembl.
DR   GO; GO:1903146; P:regulation of autophagy of mitochondrion; HMP:ParkinsonsUK-UCL.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; IEA:Ensembl.
DR   GO; GO:1901382; P:regulation of chorionic trophoblast cell proliferation; IEA:Ensembl.
DR   GO; GO:0060061; P:Spemann organizer formation; IDA:BHF-UCL.
DR   GO; GO:0007416; P:synapse assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0060715; P:syncytiotrophoblast cell differentiation involved in labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; TAS:Reactome.
DR   CDD; cd07460; CRD_FZ5; 1.
DR   Gene3D; 1.10.2000.10; -; 1.
DR   InterPro; IPR015526; Frizzled/SFRP.
DR   InterPro; IPR000539; Frizzled/Smoothened_TM.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR037441; FZ5_CRD.
DR   InterPro; IPR017981; GPCR_2-like.
DR   PANTHER; PTHR11309; PTHR11309; 1.
DR   Pfam; PF01534; Frizzled; 1.
DR   Pfam; PF01392; Fz; 1.
DR   PRINTS; PR00489; FRIZZLED.
DR   SMART; SM00063; FRI; 1.
DR   SMART; SM01330; Frizzled; 1.
DR   SUPFAM; SSF63501; SSF63501; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Developmental protein; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Golgi apparatus; Lipid-binding; Membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Wnt signaling pathway.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..585
FT                   /note="Frizzled-5"
FT                   /id="PRO_0000012990"
FT   TOPO_DOM        27..238
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        239..259
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..270
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..291
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        292..315
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        316..336
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        337..358
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        359..379
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        380..402
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        403..423
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        424..449
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        450..470
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        471..500
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        501..521
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        522..585
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..150
FT                   /note="FZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   MOTIF           525..530
FT                   /note="Lys-Thr-X-X-X-Trp motif, mediates interaction with
FT                   the PDZ domain of Dvl family members"
FT                   /evidence="ECO:0000250"
FT   MOTIF           583..585
FT                   /note="PDZ-binding"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:28377511,
FT                   ECO:0007744|PDB:5URY, ECO:0007744|PDB:5URZ"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..94
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:28377511, ECO:0007744|PDB:5URY,
FT                   ECO:0007744|PDB:5URZ"
FT   DISULFID        41..87
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:28377511, ECO:0007744|PDB:5URY,
FT                   ECO:0007744|PDB:5URZ"
FT   DISULFID        78..116
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:28377511, ECO:0007744|PDB:5URY,
FT                   ECO:0007744|PDB:5URZ"
FT   DISULFID        105..147
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:28377511, ECO:0007744|PDB:5URY,
FT                   ECO:0007744|PDB:5URZ"
FT   DISULFID        109..133
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:28377511, ECO:0007744|PDB:5URY,
FT                   ECO:0007744|PDB:5URZ"
FT   VARIANT         216
FT                   /note="P -> L (in dbSNP:rs35994626)"
FT                   /id="VAR_049291"
FT   CONFLICT        88
FT                   /note="S -> T (in Ref. 1; AAC50385)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262..263
FT                   /note="ER -> DT (in Ref. 1; AAC50385)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        345
FT                   /note="G -> A (in Ref. 1; AAC50385)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        357
FT                   /note="A -> G (in Ref. 1; AAC50385)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384
FT                   /note="D -> G (in Ref. 4; BAF83075)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="G -> R (in Ref. 1; AAC50385)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        504
FT                   /note="M -> V (in Ref. 4; BAG37738)"
FT                   /evidence="ECO:0000305"
FT   HELIX           39..41
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           60..67
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           68..70
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           71..76
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           82..90
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           106..122
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           129..131
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   HELIX           133..135
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   TURN            139..141
FT                   /evidence="ECO:0007744|PDB:6O39"
FT   STRAND          143..145
FT                   /evidence="ECO:0007744|PDB:6O39"
SQ   SEQUENCE   585 AA;  64507 MW;  AC3AB2CD912C1B0A CRC64;
     MARPDPSAPP SLLLLLLAQL VGRAAAASKA PVCQEITVPM CRGIGYNLTH MPNQFNHDTQ
     DEAGLEVHQF WPLVEIQCSP DLRFFLCSMY TPICLPDYHK PLPPCRSVCE RAKAGCSPLM
     RQYGFAWPER MSCDRLPVLG RDAEVLCMDY NRSEATTAPP RPFPAKPTLP GPPGAPASGG
     ECPAGGPFVC KCREPFVPIL KESHPLYNKV RTGQVPNCAV PCYQPSFSAD ERTFATFWIG
     LWSVLCFIST STTVATFLID MERFRYPERP IIFLSACYLC VSLGFLVRLV VGHASVACSR
     EHNHIHYETT GPALCTIVFL LVYFFGMASS IWWVILSLTW FLAAGMKWGN EAIAGYAQYF
     HLAAWLIPSV KSITALALSS VDGDPVAGIC YVGNQNLNSL RGFVLGPLVL YLLVGTLFLL
     AGFVSLFRIR SVIKQGGTKT DKLEKLMIRI GIFTLLYTVP ASIVVACYLY EQHYRESWEA
     ALTCACPGHD TGQPRAKPEY WVLMLKYFMC LVVGITSGVW IWSGKTVESW RRFTSRCCCR
     PRRGHKSGGA MAAGDYPEAS AALTGRTGPP GPAATYHKQV SLSHV
//
